Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 1997

Primary Completion Date

January 31, 2002

Conditions

Lung Cancer

Interventions

DRUG

temozolomide

Trial Locations (5)

Medical Oncology Centre of Rosebank, Johannesburg

Istituto Nazionale per la Ricerca sul Cancro, Genoa

Vrije Universiteit Medisch Centrum, Amsterdam

Medical University of Gdansk, Gdansk

Western General Hospital, Edinburgh

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00003062 - Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer | Biotech Hunter | Biotech Hunter